InsidersTradesSigma
Track the 한국유니온제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한국유니온제약 has recorded 2 insider filings. The latest transaction was reported on 4 June 2026 (Purchase). Among the most active insiders: 부광약품. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
한국유니온제약是一家韩国制药公司，专注于药品的开发和制造。该公司在韩国交易所XKRX上市。